GIPPONI, Stefano
 Distribuzione geografica
Continente #
NA - Nord America 962
EU - Europa 270
AS - Asia 133
SA - Sud America 3
AF - Africa 1
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 1.371
Nazione #
US - Stati Uniti d'America 959
CN - Cina 73
IT - Italia 61
UA - Ucraina 48
DE - Germania 36
FI - Finlandia 34
HK - Hong Kong 29
IE - Irlanda 26
GB - Regno Unito 21
SG - Singapore 19
PL - Polonia 14
FR - Francia 13
CZ - Repubblica Ceca 9
IN - India 5
BR - Brasile 3
CA - Canada 3
TR - Turchia 3
AT - Austria 2
SE - Svezia 2
VN - Vietnam 2
AU - Australia 1
BE - Belgio 1
EE - Estonia 1
EU - Europa 1
GR - Grecia 1
IR - Iran 1
MA - Marocco 1
PH - Filippine 1
RU - Federazione Russa 1
Totale 1.371
Città #
Ashburn 135
Fairfield 133
Woodbridge 84
Seattle 65
Chandler 64
Houston 60
Cambridge 54
New York 51
Ann Arbor 42
Wilmington 34
Jacksonville 32
Princeton 32
Dearborn 29
Hong Kong 28
Helsinki 25
Dublin 20
Warsaw 14
Washington 11
Shanghai 10
Boardman 8
Brescia 8
Nanchang 8
Nanjing 8
San Diego 8
Singapore 8
Beijing 6
Changsha 6
Lancaster 6
Milan 6
Brno 5
Des Moines 5
Kunming 5
London 5
Cascina 4
Cologno Monzese 4
Florence 4
Jiaxing 4
Lappeenranta 4
Olomouc 4
Taizhou 4
Verona 4
Jinan 3
Los Angeles 3
Ningbo 3
Rio De Janeiro 3
San Francisco 3
Toronto 3
Deiva Marina 2
Dong Ket 2
Guangzhou 2
Haikou 2
Kocaeli 2
Orange 2
Palermo 2
Pavia 2
Rho 2
Shenyang 2
Tianjin 2
Zhengzhou 2
Augusta 1
Brussels 1
Castiglione delle Stiviere 1
Changchun 1
Chicago 1
Chongqing 1
Cremona 1
Falkenstein 1
Hangzhou 1
Hebei 1
Hounslow 1
Kilburn 1
Leawood 1
Manila 1
Marsciano 1
Melbourne 1
Munich 1
New Bedfont 1
New Delhi 1
Norwalk 1
Pesaro 1
Pian di Scò 1
Piraeus 1
Presezzo 1
Redwood City 1
Rovato 1
Sabz 1
San Cesareo 1
San Mateo 1
Scafati 1
Seravezza 1
Siena 1
Suri 1
Taiyuan 1
Tallinn 1
Tavagnacco 1
Vienna 1
Totale 1.126
Nome #
Post-surgical therapeutic approaches to glioblastoma patients submitted to biopsy (BA) or "partial" resection (PR): the possibilities to treat also them without renunciations. Study from the Brescia Neuro-Oncology Group 143
COVID-19 impact on consecutive neurological patients admitted to the emergency department 141
The treatment of patients with 1-3 brain metastases: is there a place for whole brain radiotherapy alone, yet? A retrospective analysis 136
A neuro-oncologic challenge: the case of a large, aggressive, malignant meningioma of the skull base with paranasal sinus involvement 135
Where SUNCT Contacts TN: A Case Report 125
Potentially Serious Drug-Drug Interactions in Older Patients Hospitalized for Acute Ischemic and Hemorrhagic Stroke 114
Extrastriatal dopaminergic and serotonergic pathways in Parkinson’s disease and in dementia with Lewy bodies: a 123I-FP-CIT SPECT study 111
Pattern of relapse of glioblastoma multiforme treated with radical radio-chemotherapy: Could a margin reduction be proposed? 107
Clinical characteristics and outcomes of inpatients with neurologic disease and COVID-19 in Brescia, Lombardy, Italy 79
Plasma Cystatin C correlates with plasma NfL levels and predicts disease progression in Parkinson's disease 38
Long-term neurological manifestations of COVID-19: prevalence and predictive factors 36
Age and subtle cognitive impairment are associated with long-term olfactory dysfunction after COVID-19 infection 35
Plasma NfL, clinical subtypes and motor progression in Parkinson's disease 34
Imaging features and ultraearly hematoma growth in intracerebral hemorrhage associated with COVID-19 33
Clinical outcome of neurological patients with COVID-19: the impact of healthcare organization improvement between waves 31
Plasma neurofilament light chain predicts cognitive progression in prodromal and clinical dementia with lewy bodies 29
Neurological and Mental Health Symptoms Associated with Post-COVID-19 Disability in a Sample of Patients Discharged from a COVID-19 Ward: A Secondary Analysis 19
Predictors of “brain fog” 1 year after COVID-19 disease 19
Neurological involvement associated with COVID-19 disease: a study on psychosocial factors 18
Increased risk of functional neurological disorders following SARS‐CoV‐2 vaccination 14
Premorbid vulnerability and disease severity impact on Long-COVID cognitive impairment 13
The impact of time since SARS-Cov-2 vaccination, age, sex and comorbidities on COVID-19 outcome in hospitalized patients with SARS-CoV-2 infection 7
Totale 1.417
Categoria #
all - tutte 8.172
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.172


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020239 27 7 8 26 15 35 39 27 15 24 6 10
2020/2021347 7 53 31 18 59 52 7 21 17 28 15 39
2021/2022156 6 27 3 4 12 7 6 14 12 12 18 35
2022/2023178 18 5 2 4 33 36 2 28 31 1 8 10
2023/2024293 20 4 40 14 17 97 5 14 32 4 18 28
2024/20258 8 0 0 0 0 0 0 0 0 0 0 0
Totale 1.417